| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/05/2006 | WO2006102979A2 Inflammation markers and combinations thereof as biochemical markers for cardiovascular diseases |
| 10/05/2006 | WO2006102720A1 Isolation of inhibitor of ires-mediated translation |
| 10/05/2006 | WO2006102716A1 A method of diagnosis and treatment and agents useful for same |
| 10/05/2006 | WO2006102697A1 Fluid flow test strip for select biological substances |
| 10/05/2006 | WO2006083566A3 Biosensor based on polymer cantilevers |
| 10/05/2006 | WO2006083367A3 Immunoassay employing two-step internal calibration reaction |
| 10/05/2006 | WO2006081581A3 Atomistic model for particle inception |
| 10/05/2006 | WO2006081553A3 ANTI-MUC1 α/ß ANTIBODIES |
| 10/05/2006 | WO2006078267A3 Pathogen identification method |
| 10/05/2006 | WO2006067504A3 Low volume assay apparatus and method |
| 10/05/2006 | WO2006066049A3 Humanized antibodies that recognize beta amyloid peptide |
| 10/05/2006 | WO2006062716A3 Methods and compositions for treating ocular disorders |
| 10/05/2006 | WO2006059138A3 Measurement of soil pollution |
| 10/05/2006 | WO2006058263A3 Sensing phage-triggered ion cascade (septic) |
| 10/05/2006 | WO2006047182A3 Method and apparatus for determining an analyte concentration in a sample having interferents |
| 10/05/2006 | WO2006044946A3 Migration inhibitory factor in serum as a tumor marker for prostate, bladder, breast, ovarian, kidney and lung cancer |
| 10/05/2006 | WO2006034184A3 Use of modulators of a novel form of muscle selective calcineurin interacting protein (mcip-1-38) as a treatment for cardiovascular diseases |
| 10/05/2006 | WO2006026100A3 Methods and kits for determining metabolic stability of compounds |
| 10/05/2006 | WO2006020748A3 Gfp-snap25 fluorescence release assay for botulinum toxin protease activity |
| 10/05/2006 | WO2006015190A3 Methods of screening for antitumor agents |
| 10/05/2006 | WO2006005065A3 Luminescence characterization of quantum dots conjugated with biomarkers for early cancer detection |
| 10/05/2006 | WO2006002114A3 Tumor-associated antigen profiles in cancer diagnostics and immunotherapy |
| 10/05/2006 | WO2005116651A3 Method and device for testing for bence-jones protein |
| 10/05/2006 | WO2005112983A3 Modulation of immunoglobulin production and atopic disorders |
| 10/05/2006 | WO2005108615A3 Nucleic-acid programmable protein arrays |
| 10/05/2006 | WO2005102329A9 An innovative screening method for coronary heart disease and stroke |
| 10/05/2006 | WO2005098445A3 Lung cancer biomarkers |
| 10/05/2006 | WO2005082088A3 Functional genomics and gene trapping in haploid or hypodiploid cells |
| 10/05/2006 | WO2005056837A3 Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof |
| 10/05/2006 | WO2005044244A3 Use of mrp4-inhibitors for the treatment and/or prophylaxis of cardiovascular diseases |
| 10/05/2006 | WO2005041751A3 Sample testing device with funnel collector |
| 10/05/2006 | WO2005034840A3 Identification of kinase inhibitors |
| 10/05/2006 | WO2005013893A3 Cancer related genes |
| 10/05/2006 | WO2004058052A3 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 10/05/2006 | WO2004046317A3 Products and processes for modulating peptide-peptide binding domain interactions |
| 10/05/2006 | WO2004039832A3 Leptin-related peptides |
| 10/05/2006 | WO2004016736A3 Nucleic acids and corresponding proteins entitled 202p5a5 useful in treatment and detection of cancer |
| 10/05/2006 | WO2004015065A3 Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays |
| 10/05/2006 | WO2003087761A3 Molecular profiling of disease and therapeutic response using phospho-specific antibodies |
| 10/05/2006 | WO2003087306A8 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 10/05/2006 | WO2003074652A3 Methods for identifying agents that modulate mast cell degranulation |
| 10/05/2006 | WO2003069312A3 Molecular sensors by competitive activation |
| 10/05/2006 | WO2003066834A3 Composition and method for modulating an inflammatory response |
| 10/05/2006 | WO2003004992A3 Mammalian sweet and amino acid heterodimeric taste receptors |
| 10/05/2006 | US20060225143 Animal exhibiting ptsd-like behavior, per pct rule 4.3 |
| 10/05/2006 | US20060224658 Sample analyzing method and sample analyzing device |
| 10/05/2006 | US20060224529 Artificial intelligence and global normalization methods for genotyping |
| 10/05/2006 | US20060224331 Protein fragment complementation assays for high-throughput and high-content screening |
| 10/05/2006 | US20060223990 Synthesis, deprotection, analysis & purification of RNA & ribozymes |
| 10/05/2006 | US20060223862 administration of catalytic iron chelator compound, then urine screening for creatinine levels |
| 10/05/2006 | US20060223860 e.g. 3-(4-{[6-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)-phenyl]ethyl}amino)-hexyl]oxy}butyl)benzenesulfonamide; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist activity; bronchodilator agent; pulmonary disorders: chronic obstructive pulmonary dusease; asthma |
| 10/05/2006 | US20060223859 Chronic obstructive pulmonary dusease; asthma |
| 10/05/2006 | US20060223858 Chronic obstructive pulmonary dusease; asthma |
| 10/05/2006 | US20060223839 5-(1',1'-cycloalkyl/alkenyl)methylidene 1,2-dihydro-5H-chromeno-[3,4-f]-quinolines as selective progesterone receptor modulator compounds |
| 10/05/2006 | US20060223779 Method of screening for inhibitors of human Fatty Acid-CoA Ligase 4 |
| 10/05/2006 | US20060223771 Nuclear factor kappaB inducing factor |
| 10/05/2006 | US20060223767 Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene therapy |
| 10/05/2006 | US20060223752 Of pestviruses as drug delivery devices for type-specific diagnosis of infection, for eliciting antibiotic activity, and for transport of substances into a cell |
| 10/05/2006 | US20060223197 Method and apparatus for the detection of biological molecules |
| 10/05/2006 | US20060223196 Method and system for controllably releasing solutions |
| 10/05/2006 | US20060223195 Stress based removal of nonspecific binding from surfaces |
| 10/05/2006 | US20060223194 Methods of screening for post-translationally modified proteins |
| 10/05/2006 | US20060223193 Diagnostic test kits employing an internal calibration system |
| 10/05/2006 | US20060223192 Rapid test for glycated albumin |
| 10/05/2006 | US20060223190 Nitrogen oxide analyzer and method for setting parameter applied to nitrogen oxide analyzer |
| 10/05/2006 | US20060223189 Solid-phase saccharide sensing compounds |
| 10/05/2006 | US20060223187 Preparation of platelet analogs |
| 10/05/2006 | US20060223181 Method for separating hepatic progenitor cell |
| 10/05/2006 | US20060223167 Biochip support comprising thin layers of sol-gel material and production method thereof |
| 10/05/2006 | US20060223166 Mesoscale detection structures |
| 10/05/2006 | US20060223165 Device for counting cells and method for manufacturing the same |
| 10/05/2006 | US20060223164 Microfluidic systems for altering the solution environment around a nanoscopic or microscopic object, such as a sensor; applied in any sensor technology in which the sensing element needs to be exposed rapidly, sequentially, and controllably, to a large number of different solution environments |
| 10/05/2006 | US20060223143 Methods and compositions for polypeptide engineering |
| 10/05/2006 | US20060223141 Transcription amplification system for molecular imaging |
| 10/05/2006 | US20060223139 Use of fluorinated fluids as storage liquid for preserved biological specimens |
| 10/05/2006 | US20060223138 Erythrocytes in the specimen are lysed and nucleic acid in the megakaryocytes is stained with a fluorescent dye, the cells are irradiated with excited light so that forward scattered light, side scattered light and the fluorescence are detected and the cells are counted |
| 10/05/2006 | US20060223134 For quantification and monitoring of doxorubicin in biological fluids; using antibodies that selectively bind to doxorubicin without any substantial cross reactivity to non-pharmaceutically active doxorubicin metabolites particularly doxorubicin aglycone. |
| 10/05/2006 | US20060223133 Comprises immunoglobulin for treating arteriosclerosis, cancer and skin disorders; immunoassays; restenosis |
| 10/05/2006 | US20060223132 Phenethanolamine-derived haptens, immunogens, antibodies and conjugates |
| 10/05/2006 | US20060223131 Protein arrays and methods of use thereof |
| 10/05/2006 | US20060223130 Detection of post-translationally modified analytes |
| 10/05/2006 | US20060223129 Compounds for immunodiagnosis of prostate cancer and methods for their use |
| 10/05/2006 | US20060223128 Method for detecting multi-drug resistance |
| 10/05/2006 | US20060223127 Serum biomarkers in lung cancer |
| 10/05/2006 | US20060223126 Magnetic particles having porous surfaces, method of producing the same, carrier for biochemical use, and biotin-bonding particles |
| 10/05/2006 | US20060223125 Methods and kits for staining cell membranes |
| 10/05/2006 | US20060223124 Amphiphilic mediated sample preparation for micro-flow cytometry |
| 10/05/2006 | US20060223123 nucleic acid encoding Macaca mulatta (rhesus monkey) Nur77 nuclear receptor (rhNur77); useful for treating or inhibiting inflammatory diseases such as osteoarthritis and various bone, neurological, and prostrate disorders, and cancer; drug screening; biodrug; culturing |
| 10/05/2006 | US20060223122 Classifying and predicting glomerulosclerosis using a proteomics approach |
| 10/05/2006 | US20060223121 Contacting biological sample of urine, cerebrospinal fluid or serum with a peptide and complexing with a monoclonal antibody ligand; detecting an immunogenic peptide having calgranulin B protein activity; Alzheimer's and Parkinson's disease, amyotrophic lateral sclerosis; rheumatoid arthritis |
| 10/05/2006 | US20060223120 High-throughput method for optimum solubility screening for homogeneity and crystallization of proteins |
| 10/05/2006 | US20060223119 Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism |
| 10/05/2006 | US20060223118 Screening of chemical compounds purified from biological sources |
| 10/05/2006 | US20060223117 Novel splice variants of human epithelial sodium channel genes expressed in human taste tissue and uses thereof |
| 10/05/2006 | US20060223115 Heterotrimeric G-protein |
| 10/05/2006 | US20060223113 Immobilization of binding agents |
| 10/05/2006 | US20060223112 Novel receptor |
| 10/05/2006 | US20060223111 Biosensor system that enables spectral multiplexing |
| 10/05/2006 | US20060223110 Drug design; use of machine-readable data storage media comprising structure coordinates of Site II |
| 10/05/2006 | US20060223109 G protein-coupled receptors |